PHARMA MAR, S.A.
Headquarters address: Av. de los Reyes, 1, 28770 Colmenar Viejo - Madrid
CIF A78267176 Spain Pharmaceutical Chemical industry seen 1392 times Last report June 2020
Employees | 317 (60.60% women) |
Profit | 123.7M € |
Indebtedness | 240.3% |
Income | 213.5M € |
Earnings per share | 0.51 € |
Solvency | 141.6% | 33.14% |
Short solvency | 230.4% | 239.1% |
Working balance on income | 70.73% | 680.2% |
Working balance on assets | 58.21% | 378% |
Non current assets coverage | 115.8% | 661% |
Fixed assets on long term debt | 76.58% | 282.5% |
Cash on Current Assets | 80.51% | 128.1% |
Inmovilization | 26.33% | -56.05% |
Cash on Current Liabilities | 192.6% | 560.1% |
Leverage | 16.88% | -74.55% |
Debt Quality | 56.4% | 16.4% |
Financial Expenses Coverage | 2.58K% | -804.7% |
Short term Indebtedness | 104.8% | -87.07% |
Long term Indebtedness | 135.5% | -82.21% |
Financial Expenses on EBIT | 3.88% | -114.2% |
Indebtedness Ratio | 70.62% | -24.89% |
Indebtedness on EBIT | 223.6% | -133.4% |
Assets Turnover | 60.62% | -11.91% |
Customers Turnover | -1.17K% | 56.92% |
Fixed Assets Turnover | 230.2% | 100.4% |
Suppliers Turnover | 41.53% | 33.46% |
Profit on Income/Sales | 57.96% | -537.1% |
Earnings per share | 0.51 € | -610% |
Funds from Operations | 131.5M € | -4.03K% |
EBIT Margin | 52.09% | -355.6% |
Operating Margin | 51.23% | -303% |
ROA | 35.13% | -485% |
ROE | 115.2% | -215.1% |
Profitability | 30.36% | -340.9% |
Economic Profitability | 31.58% | -325.2% |
Rea Estate Profitability | -273.5% | 401.7% |
Expenses/Profit | 40.61% | -116.8% |
EBIT | -2.58K% | -804.7% |
Staff expenses | 142.5K € | 3.62% |
Financial Expenses on Sales | 2.02% | -63.72% |
Cash Flow per share | 698.8K | -1.66K% |
Cash Flow on assets | 48.14% | -1.28K% |
Cash Flow on income/sales | 79.41% | -1.43K% |
Dividends on Cash Flow | 0% | 0% |
Cash Flow Margin Ratio | 120.6% | -496.1% |
Cash Flow on short-term Liabilities | -156.4% | -1.95K% |
Cash Flow on long-term Liabilities | -120.9% | -1.45K% |
Cash Flow on Debt | -285.2% | -4.72K% |
External Financing | -28.96% | -113.4% |